SCHEMBL6978066

SCHEMBL6978066

Cc1cn2c3ccc(Br)cc3c3cc(OCc4cccnc4)cc(c1=O)c32

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.40
GABRA5 P31644 1/20 0.40
PKM P14618 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
HIF1A Q16665 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GRM2 Q14416 1/20 0.38
ADAM17 P78536 2/20 0.38
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37
MAOA P21397 1/20 0.37
DYRK1A Q13627 1/20 0.37
BRD4 O60885 1/20 0.36
CREBBP Q92793 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6973159 0.92 GABRA1 (0.40) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6979179 0.89 GABRA1 (0.39) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6982487 0.85 LRRK2 (0.38) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL7673377 0.85 GABRA1 (0.39) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6978806 0.84 GRM2 (0.41) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6983481 0.82 GABRA1 (0.38) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6981580 0.82 GABRA1 (0.35) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6977199 0.81 GABRA1 (0.39) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6981582 0.81 FPR1 (0.34) GABRA1GABRA5PKMALDH1A1MAPT
SCHEMBL6983183 0.80 CNR1 (0.37) GABRA1GABRA5PKMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed